Skip to content

Clinical trials

Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: United States Clear all

415 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
200110
20021
20039
20046
200511
20068
20078
200811
200910
201015
201116
201215
201322
201423
201520
201623
201722
201818
201914
202013
202123
202218
202322
202421
202519
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed221
Recruiting64
Terminated53
Active, not recruiting26
Unknown status17
Withdrawn16
Not yet recruiting8
Enrolling by invitation6
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)26
Gilead Sciences17
Massachusetts General Hospital12
Hunter Holmes Mcguire Veteran Affairs Medical Center11
Virginia Commonwealth University11
Mayo Clinic9
University of Michigan9
VA Office of Research and Development8
NYU Langone Health7
University of California, San Francisco7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis415
Hepatitis C50
Liver Diseases49
Non-alcoholic Fatty Liver Disease49
Liver Cirrhosis43
Hepatic Encephalopathy34
Carcinoma, Hepatocellular31
Ascites27
Fatty Liver26
Hypertension, Portal23

Trials

Showing 76 to 100 of 415. Each trial links to its page on Pharma Observatory.

315 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.